Cargando…

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab

Detalles Bibliográficos
Autores principales:	Vellas, Camille, Trémeaux, Pauline, Del Bello, Arnaud, Latour, Justine, Jeanne, Nicolas, Ranger, Noémie, Danet, Chloé, Martin-Blondel, Guillaume, Delobel, Pierre, Kamar, Nassim, Izopet, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112603/ https://www.ncbi.nlm.nih.gov/pubmed/35595125 http://dx.doi.org/10.1016/j.cmi.2022.05.002

Ejemplares similares

Impact of Casirivimab-Imdevimab on Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Nasopharyngeal Virus Load and Spike Quasispecies
por: Vellas, Camille, et al.
Publicado: (2022)

Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies
por: Vellas, Camille, et al.
Publicado: (2022)

Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment
por: Vellas, Camille, et al.
Publicado: (2022)

Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Whole‐genome sequencing of SARS‐CoV‐2: Comparison of target capture and amplicon single molecule real‐time sequencing protocols
por: Nicot, Florence, et al.
Publicado: (2022)

Prediction of SARS-CoV-2 Variant Lineages Using the S1-Encoding Region Sequence Obtained by PacBio Single-Molecule Real-Time Sequencing
por: Lhomme, Sébastien, et al.
Publicado: (2021)

Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study
por: Faguer, Stanislas, et al.
Publicado: (2022)

SARS-CoV-2 Co-Infections and Recombinations Identified by Long-Read Single-Molecule Real-Time Sequencing
por: Trémeaux, Pauline, et al.
Publicado: (2023)

Classification of the Zoonotic Hepatitis E Virus Genotype 3 Into Distinct Subgenotypes
por: Nicot, Florence, et al.
Publicado: (2021)

Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients?
por: Del Bello, Arnaud, et al.
Publicado: (2022)

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
por: Kamar, Nassim, et al.
Publicado: (2021)

Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant
por: Migueres, Marion, et al.
Publicado: (2022)

Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients
por: Del Bello, Arnaud, et al.
Publicado: (2022)

Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients
por: Kamar, Nassim, et al.
Publicado: (2022)

Omicron Wave SARS-CoV-2 Diagnosis: Evaluation of Saliva, Anterior Nasal, and Nasopharyngeal Swab Samples
por: Migueres, Marion, et al.
Publicado: (2022)

Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
por: Kamar, Nassim, et al.
Publicado: (2021)

Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates
por: Mehawej, Mireille, et al.
Publicado: (2015)

Effectiveness of Sotrovimab in the Omicron Storm Time: A Case Series
por: Cicchitto, Gaetano, et al.
Publicado: (2022)

COVID-19, Virology and Geroscience: A Perspective
por: Vellas, Camille, et al.
Publicado: (2020)

Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
por: Chavarot, Nathalie, et al.
Publicado: (2022)

Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2
por: Martin-Blondel, Guillaume, et al.
Publicado: (2022)

Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19
por: Lafaurie, Margaux, et al.
Publicado: (2021)

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer
por: Wu, Mary Y., et al.
Publicado: (2023)

Will the latest wave of the COVID‐19 pandemic be an ecological disaster? There is an urgent need to replace plastic by ecologically virtuous materials
por: Mansuy, Jean‐Michel, et al.
Publicado: (2022)

Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
por: Destras, Grégory, et al.
Publicado: (2022)

Hepatitis E Virus Quasispecies in Cerebrospinal Fluid with Neurological Manifestations
por: Abravanel, Florence, et al.
Publicado: (2021)

Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases
por: Focosi, Daniele, et al.
Publicado: (2022)

Sotrovimab for COVID-19
Publicado: (2021)

Sotrovimab: First Approval
por: Heo, Young-A
Publicado: (2022)

Predictive Factors for Humoral Response After 2-dose SARS-CoV-2 Vaccine in Solid Organ Transplant Patients
por: Marion, Olivier, et al.
Publicado: (2021)

Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study)
por: Martin-Blondel, Guillaume, et al.
Publicado: (2022)

Clinical Manifestations, Pathogenesis and Treatment of Hepatitis E Virus Infections
por: Lhomme, Sébastien, et al.
Publicado: (2020)

Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants
por: Migueres, M., et al.
Publicado: (2021)

Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2021)

Weaker Effects of the Fourth Dose of BNT162b2 SARS-CoV-2 Vaccine on the Elderly Human Population
por: Dimeglio, Chloé, et al.
Publicado: (2023)

Comparative effects of mRNA vaccine booster and natural Omicron infection on the neutralizing antibody response
por: Dimeglio, Chloé, et al.
Publicado: (2022)

Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals
por: Mader, Anna-Lena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t8fojkua4fe2sq5kn34bvasssc